Thomas P. Cujec

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 497 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II

Thomas P. Cujec, Hiroshi Okamoto, Koh Fujinaga et al. · Genes & Development · 1997 · 194 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 175 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

The Ability of Positive Transcription Elongation Factor b To Transactivate Human Immunodeficiency Virus Transcription Depends on a Functional Kinase Domain, Cyclin T1, and Tat

Koh Fujinaga, Thomas P. Cujec, Junmin Peng et al. · Journal of Virology · 1998 · 160 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17

Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T

Koh Fujinaga, Ran Taube, Jörg Wimmer et al. · Proceedings of the National Academy of Sciences · 1999 · 121 citations

Life Sciences, Molecular Biology, Molecular Genetics +13